SR One Capital Management, LP
Redwood City, CA · CIK 1910264 · 13F filing filed 2024-05-13
SEC-registered investment adviser since 2020 · limited partnership
- Assets managed$2.4bn
- Staff28 · 15 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds19 · $2.4bn gross assets
- Websitesrone.com
- Form ADV · 2026-03-31SEC adviser record
- Kindprivate equity
- Others nearbyRedwood City, CA, London
As an employer
- Offices in2 countries
- Private fundsprivate equity 19
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| Redwood City, CA (main office)United States | about 10 |
| LondonUnited Kingdom | 5 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
$364.1m
reported value
+52.9% vs Q4 2023
6positions
100.0%in top 10
1 new
2 added
1 reduced
0 sold out
vs Q4 2023
Holdings, Q1 2024
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ARCELLX INC ACLX | $163.2m44.83% | Reduced -800.0k |
| CRISPR THERAPEUTICS AG CRSP | $71.5m19.64% | New |
| ARS PHARMACEUTICALS INC SPRY | $41.0m11.26% | Unchanged |
| NKARTA INC NKTX | $36.0m9.90% | Added +2.0m |
| DESIGN THERAPEUTICS INC DSGN | $26.3m7.22% | Unchanged |
| MINERALYS THERAPEUTICS INC MLYS | $26.0m7.15% | Added +222.2k |